Archives of Critical Care Medicine

Published by: Kowsar
Corrected Proof scheduled for 2 (1)

Evaluation of Vancomycin Administration After Pharmacist Intervention in the Intensive Care Unit of an Educational Hospital

Authors Information
1 Student Research Committee, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Clinical Pharmacy, Faculty of Pharmacy-International Campus, Iran University of Medical Sciences, Tehran, IR Iran
3 Clinical Research Development Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
4 Department of Clinical Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article Notes and Dates
Archives of Critical Care Medicine: , In Press (In Press); e9037.Published Online: January 31, 2016
Article Type: Research Article; Received : December 14, 2015; Accepted : January 16, 2016
DOI: http://dx.doi.org/10.5812/accm.9037

To Cite : Mohammadi M, Eshraghi A, Hajiesmaeili M, Sahraei Z. Evaluation of Vancomycin Administration After Pharmacist Intervention in the Intensive Care Unit of an Educational Hospital, Arch Crit Care Med. Online ahead of Print ;In Press(In Press):e9037. doi: 10.5812/accm.9037.

Abstract
Copyright: Copyright © 2016, Archives of Critical Care Medicine. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
References
  • 1. Textbookofbacteriology. TODAR's online textbook of bacteriology. Antimicrobial Agents in the Treatment of Infectious Disease. 2016. Available from: http://textbookofbacteriology.net/antimicrobial_3.html.
  • 2. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet. 1988;1(8575-6):57-8. [PubMed: 2891921].
  • 3. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987;316(15):927-31. doi: 10.1056/NEJM198704093161507. [PubMed: 3821839].
  • 4. Stolar MH. Drug use review: operational definitions. Am J Hosp Pharm. 1978;35(1):76-8. [PubMed: 623123].
  • 5. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. P T. 2015;40(4):277-83. [PubMed: 25859123].
  • 6. Allen NE, Nicas TI. Mechanism of action of oritavancin and related glycopeptide antibiotics. FEMS Microbiol Rev. 2003;26(5):511-32. [PubMed: 12586393].
  • 7. Salehifar E, Babamahmoodi F, Alikhani A, Ganji R, Fazli M. Drug utilization evaluation of vancomycin in a referral infectious center in mazandaran province. J Pharm Care. 2015;2(2):55-9.
  • 8. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006;42(3):389-91. doi: 10.1086/499367. [PubMed: 16392087].
  • 9. von Gunten V, Reymond JP, Boubaker K, Gerstel E, Eckert P, Luthi JC, et al. Antibiotic use: is appropriateness expensive?. J Hosp Infect. 2009;71(2):108-11. doi: 10.1016/j.jhin.2008.10.026. [PubMed: 19062133].
  • 10. Fahimi F, Soleymani F, Tavakoli-Ardakani M. Vancomycin Utilization Evaluation in a teaching hospital: A case-series study in Iran. J Pharm Care. 2015;1(2):51-4.
  • 11. Vazin A, Japoni A, Shahbazi S, Davarpanah MA. Vancomycin utilization evaluation at hematology-oncology ward of a teaching hospital in iran. Iran J Pharm Res. 2012;11(1):163-70. [PubMed: 24250438].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Cited By:

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader